Your Path to Trial Virtualization: Sponsor Edition


Your Path to Trial Virtualization
Sponsor Edition

The COVID-19 pandemic drove 45% of clinical trial sites to transition patients from in-person to remote visits using virtual trial solutions.1

Disruptions preventing or limiting site access to patients, monitors, and CRAs are propelling long-lasting changes in the research industry, supported by the adoption of virtualization technologies.

  • Are you prepared to adopt a virtualization strategy?
  • Can you respond to urgent remote requirements for patients and sites?
  • Have you and your CRO evolved your technology approach to support fully remote study conduct?
  • Will your strategy meet future standards for transforming trials?

To get additional information about the parameters driving a successful response and approach to virtualization, download the eBook now.

If you have yet to take our three-minute assessment across 8 parameters to discover and initiate the next steps toward your own, customized “Path to Virtualization,” start here.

1. Medidata: Clinical Trial Sites Share Frontline Insights into COVID-19 Impact

<strong>Your Path to Trial Virtualization</strong><br>Sponsor Edition